Legal & General Group
UPB

Legal & General Group’s Upstream Bio Inc UPB Stock Holding History

Legal & General Group’s Portfolio UPB Stock Details UPB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86.9K Buy
12,561
+2,952
+31% +$24.7K ﹤0.01% 2655
2026
Q1 		$86.5K Sell
9,609
-4,100
-30% -$73.8K ﹤0.01% 2622
2025
Q4 		$372K Buy
13,709
+10,785
+369% +$268K ﹤0.01% 2495
2025
Q3 		$55K Sell
2,924
-250
-8% -$3.88K ﹤0.01% 2712
2025
Q2 		$34.9K Buy
3,174
+1,440
+83% +$13.3K ﹤0.01% 2795
2025
Q1 		$10.6K Hold
1,734
– – ﹤0.01% 3157
2024
Q4 		$28.5K Buy
+1,734
New +$38.7K ﹤0.01% 2905

Other funds holding UPB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Legal & General Group's UPB Position: Q2 2026 in Review

Legal & General Group increased its Upstream Bio Inc (UPB) stake by 31% in Q2 2026, buying an estimated $24.7K and bringing the position to 12,561 shares worth $86.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2655.

Legal & General Group first reported a position in UPB in Q4 2024 and has held it in 7 quarters since. The position peaked at $372K in Q4 2025. 148 funds tracked by Wall St. Rank hold UPB as of Q2 2026.

  • Legal & General Group held 12,561 shares of Upstream Bio Inc worth $86.9K as of Q2 2026.
  • Legal & General Group bought 2,952 Upstream Bio Inc shares in Q2 2026, an estimated $24.7K.
  • Upstream Bio Inc made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2655 holding.
  • Legal & General Group first reported a position in Upstream Bio Inc in Q4 2024 and has held it in 7 quarters since.
  • Legal & General Group's Upstream Bio Inc position peaked at $372K in Q4 2025.
  • 148 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.